GQ1007 / GeneQuantum Healthcare, BrighGene  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GQ1007 / GeneQuantum Healthcare, BrighGene
ACTRN12622000513718: A First-In-Human, Dose Escalation and Expansion Study of GQ1007 Alone and in Combination with Envafolimab in Subjects with HER2-expressing Advanced Solid Tumors

Withdrawn
1
200
 
GeneQuantum Healthcare (Suzhou) Co., Ltd. , GeneQuantum Healthcare (Suzhou) Co., Ltd.
Solid Tumors
 
 

Download Options